Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

Failures in Alzheimer's disease (AD) drug trials highlight the need to further explore disease mechanisms and alterations of biomarkers during the development of AD. Using cross‐sectional data from 377 participants in the BioFINDER study, we examined seven cerebrospinal fluid (CSF) and six plas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EMBO Mol Med
Main Authors: Palmqvist, Sebastian, Insel, Philip S, Stomrud, Erik, Janelidze, Shorena, Zetterberg, Henrik, Brix, Britta, Eichenlaub, Udo, Dage, Jeffrey L, Chai, Xiyun, Blennow, Kaj, Mattsson, Niklas, Hansson, Oskar
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6895602/
https://ncbi.nlm.nih.gov/pubmed/31709776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados